Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYTK | KRYS | NUVL | ||
| Company | Cytokinetics | Krystal Biotech Inc | Nuvalent Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 60.92 | 266.93 | 101.13 | ||
| High | 62.57 | 266.99 | 104.11 | ||
| Low | 60.01 | 257.44 | 99.18 | ||
| Latest | 62.27 | 265.00 | 102.67 | ||
| Change | +1.55 | +1.20 | +2.45 | ||
| % Change | +2.55% | +0.45% | +2.44% | ||
| Volume | 2,369,500 | 234,800 | 590,500 | ||
| 20-Day Average Volume | 1,929,430 | 320,030 | 511,050 | ||
| Previous Close | 60.72 | 263.80 | 100.22 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 64.61 | 271.07 | 102.58 | ||
| 20-Day Raw Stochastic | 26.62% | 27.12% | 46.65% | ||
| 20-Day Relative Strength | 46.46 | 49.20 | 49.60 | ||
| Weighted Alpha | +21.52 | +65.84 | +43.84 | ||
| Today's Opinion | 40% Buy | 64% Buy | 64% Buy | ||
| Previous Opinion | 40% Buy | 64% Buy | 32% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.99% since 02/25/26 | -2.75% since 02/25/26 | -1.78% since 02/25/26 | ||
| Low | 59.33 on 03/03/26 | 253.70 on 03/03/26 | 97.24 on 03/03/26 | ||
| High | 63.00 on 02/26/26 | 277.03 on 02/26/26 | 105.83 on 02/26/26 | ||
| 1-Month | |||||
| %Chg | -1.97% since 02/04/26 | -1.53% since 02/04/26 | -2.21% since 02/04/26 | ||
| Low | 59.33 on 03/03/26 | 252.61 on 02/20/26 | 97.24 on 03/03/26 | ||
| High | 70.39 on 02/24/26 | 298.30 on 02/17/26 | 108.88 on 02/05/26 | ||
| 3-Month | |||||
| %Chg | -6.42% since 12/04/25 | +19.39% since 12/04/25 | -3.92% since 12/04/25 | ||
| Low | 58.85 on 01/05/26 | 220.79 on 12/05/25 | 95.50 on 01/05/26 | ||
| High | 70.98 on 12/22/25 | 298.30 on 02/17/26 | 113.01 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +25.17% since 09/04/25 | +76.96% since 09/04/25 | +28.87% since 09/04/25 | ||
| Low | 47.22 on 09/25/25 | 136.73 on 09/10/25 | 74.40 on 09/08/25 | ||
| High | 70.98 on 12/22/25 | 298.30 on 02/17/26 | 113.01 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,478,458 | 7,711,401 | 7,286,696 | ||
| Shares Outstanding, K | 123,163 | 29,232 | 72,707 | ||
| Annual Sales | 88,040,000 | 389,130,000 | 0 | ||
| Annual Net Income | -784,960,000 | 204,830,000 | -425,380,000 | ||
| Last Quarter Sales | 17,760,000 | 107,110,000 | 0 | ||
| Last Quarter Net Income | -183,030,000 | 51,400,000 | -118,710,000 | ||
| 60-Month Beta | 0.56 | 0.49 | 1.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.50 on 02/24/26 | 1.70 on 02/17/26 | 1.58 on 02/26/26 | ||
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 37.78 | 0.00 | ||